Basel Medical Group Ltd Ordinary Shares(BMGL)

Medical - Care Facilities · Singapore, CE

$3.17-0.11 (-3.35%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

Price/FCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/FCF ratio is N/A as of 2026-10-06T12:50:45.952Z.

Stored calculation inputs

Calculation as of: 2026-10-06T12:50:45.952Z.

Quote observation: 2026-10-05T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 4,962,572
TTM free cash flow · period ending 2025-12-31: N/A

FMP input reference: 3f32b4356dd318fc5fc0a902c875af90b1a094ceb52f500a6b854293a5898a5a

P/E Ratio|FCF Growth|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

BMGL Price/FCF Ratio Metrics

PRICE/FCF RATIO

N/A

BMGL Competitors' Price/FCF Ratio

BMGL

Basel Medical Group Ltd Ordinary Shares

Current

Market Cap

$4.96M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GELS

Gelteq Limited Ordinary Shares

vs BMGL

Market Cap

$4.99M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CALC

CalciMedica, Inc.

vs BMGL

Market Cap

$4.85M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BGMS

Bio Green Med Solution, Inc.

vs BMGL

Market Cap

$4.79M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMNN

Imunon, Inc.

vs BMGL

Market Cap

$5.21M

Price/FCF Ratio

N/A

TTM Avg

15.88

3Y Avg

17.94

5Y Avg

17.94

ALZN

Alzamend Neuro Inc

vs BMGL

Market Cap

$5.36M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DRMA

Dermata Therapeutics, Inc.

vs BMGL

Market Cap

$4.46M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CLGN

CollPlant Biotechnologies Ltd.

vs BMGL

Market Cap

$4.42M

Price/FCF Ratio

N/A

TTM Avg

63.09

3Y Avg

63.09

5Y Avg

63.09

ERNA

Ernexa Therapeutics Inc.

vs BMGL

Market Cap

$4.41M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INBS

Intelligent Bio Solutions Inc.

vs BMGL

Market Cap

$5.54M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
Basel Medical Group Ltd Ordinary Shares (BMGL)	$4.96M	N/A	N/A	N/A	N/A
Gelteq Limited Ordinary Shares (GELS)vs ›	$4.99M	N/A	N/A	N/A	N/A
CalciMedica, Inc. (CALC)vs ›	$4.85M	N/A	N/A	N/A	N/A
Bio Green Med Solution, Inc. (BGMS)vs ›	$4.79M	N/A	N/A	N/A	N/A
Imunon, Inc. (IMNN)vs ›	$5.21M	N/A	15.88	17.94	17.94
Alzamend Neuro Inc (ALZN)vs ›	$5.36M	N/A	N/A	N/A	N/A
Dermata Therapeutics, Inc. (DRMA)vs ›	$4.46M	N/A	N/A	N/A	N/A
CollPlant Biotechnologies Ltd. (CLGN)vs ›	$4.42M	N/A	63.09	63.09	63.09
Ernexa Therapeutics Inc. (ERNA)vs ›	$4.41M	N/A	N/A	N/A	N/A
Intelligent Bio Solutions Inc. (INBS)vs ›	$5.54M	N/A	N/A	N/A	N/A

Free Cash Flow Valuation

P/FCF Ratio

N/A

FCF Yield

N/A

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/FCF Ratio: N/A

BMGL Price/FCF Ratio Metrics

BMGL Competitors' Price/FCF Ratio

Free Cash Flow Valuation

Price/FCF Ratio Formula & Definition

Related Metrics